Huuhtanen J, Kasanen HH, Peltola K, Lönnberg T, Glumoff V, Brück O, Dufva O, Peltonen K, Vikkula J, Jokinen E, Ilander M, Lee MH, Mäkelä S, Nyakas M, Li B, Hernberg M, Bono P, Lähdesmäki H, Kreutzman A, Mustjoki S(2023) Single-cell characterization of anti-LAG3+anti-PD1 treatment in melanoma patients J Clin Invest(in press) DOI 10.1172/JCI164809, PubMed 36719749
Piperno-Neumann S, Carlino MS, Boni V, Loirat D, Speetjens FM, Park JJ, Calvo E, Carvajal RD, Nyakas M, Gonzalez-Maffe J, Zhu X, Shirley MD, Ramkumar T, Fessehatsion A, Burks HE, Yerramilli-Rao P, Kapiteijn E(2023) A phase I trial of LXS196, a protein kinase C (PKC) inhibitor, for metastatic uveal melanoma Br J Cancer(in press) DOI 10.1038/s41416-022-02133-6, PubMed 36624219
Rowsell A, Sodergren SC, Vassiliou V, Darlington AS, Guren MG, Alkhaffaf B, Moorbey C, Dennis K, Terada M(2023) Correction to: Systematic review of health-related quality of life (HRQoL) issues associated with gastric cancer: capturing cross-cultural differences Gastric Cancer, 26(1), 167 DOI 10.1007/s10120-022-01346-1, PubMed 36269499
